Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafne Müller

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Oncoimmunology|December 22, 2016
Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain formatSina Fellermeier, Nadine Beha, Jan-Erik Meyer, et al.
Protein Engineering, Design & Selection : PEDS|September 7, 2010
The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion proteinJonas Hopp, Nora Hornig, Kirstin A Zettlitz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 27, 2010
Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systemsMiriam Rothdiener, Dafne Müller, Patricia Garrido Castro, et al.
Cancer Research|July 19, 2014
miR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasionAnnabell Bischoff, Bettina Huck, Bettina Keller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Tumor-specific crosslinking of GITR as costimulation for immunotherapyTanja Burckhart, Markus Thiel, Hiroyoshi Nishikawa, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Oncoimmunology|December 22, 2016
Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain formatSina Fellermeier, Nadine Beha, Jan-Erik Meyer, et al.
Protein Engineering, Design & Selection : PEDS|September 7, 2010
The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion proteinJonas Hopp, Nora Hornig, Kirstin A Zettlitz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 27, 2010
Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systemsMiriam Rothdiener, Dafne Müller, Patricia Garrido Castro, et al.
Cancer Research|July 19, 2014
miR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasionAnnabell Bischoff, Bettina Huck, Bettina Keller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Tumor-specific crosslinking of GITR as costimulation for immunotherapyTanja Burckhart, Markus Thiel, Hiroyoshi Nishikawa, et al.
Pageof 4